Alta Partners Ii Inc - Net Worth and Insider Trading

Alta Partners Ii Inc Net Worth

The estimated net worth of Alta Partners Ii Inc is at least $97,742 dollars as of 2024-11-10. Alta Partners Ii Inc is the 10% Owner of Rigel Pharmaceuticals Inc and owns about 4,457 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $97,742. Details can be seen in Alta Partners Ii Inc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alta Partners Ii Inc has not made any transactions after 2004-05-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alta Partners Ii Inc

To

Alta Partners Ii Inc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alta Partners Ii Inc owns 2 companies in total, including Corcept Therapeutics Inc (CORT) , and Rigel Pharmaceuticals Inc (RIGL) .

Click here to see the complete history of Alta Partners Ii Inc’s form 4 insider trades.

Insider Ownership Summary of Alta Partners Ii Inc

Ticker Comapny Transaction Date Type of Owner
CORT Corcept Therapeutics Inc 2007-08-17 10 percent owner
RIGL Rigel Pharmaceuticals Inc 2004-05-07 10 percent owner

Alta Partners Ii Inc Latest Holdings Summary

Alta Partners Ii Inc currently owns a total of 1 stock. Alta Partners Ii Inc owns 4,457 shares of Rigel Pharmaceuticals Inc (RIGL) as of May 7, 2004, with a value of $97,742.

Latest Holdings of Alta Partners Ii Inc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RIGL Rigel Pharmaceuticals Inc 2004-05-07 4,457 21.93 97,742

Holding Weightings of Alta Partners Ii Inc


Alta Partners Ii Inc Form 4 Trading Tracker

According to the SEC Form 4 filings, Alta Partners Ii Inc has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 310 shares on May 7, 2004, which brought Alta Partners Ii Inc around $66,650.

Insider Trading History of Alta Partners Ii Inc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alta Partners Ii Inc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alta Partners Ii Inc Ownership Network

Ownership Network List of Alta Partners Ii Inc

No Data

Ownership Network Relation of Alta Partners Ii Inc

Insider Network Chart

Alta Partners Ii Inc Owned Company Details

What does Corcept Therapeutics Inc do?

Who are the key executives at Corcept Therapeutics Inc?

Alta Partners Ii Inc is the 10 percent owner of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Development Officer William Guyer , CHIEF FINANCIAL OFFICER Gary Charles Robb , and Chief Accounting Officer Joseph Douglas Lyon .

Corcept Therapeutics Inc (CORT) Insider Trades Summary

Over the past 18 months, Alta Partners Ii Inc made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 70,000 shares made by Joseph Douglas Lyon , a net sale of 28,750 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .

In summary, during the past 3 months, insiders sold 44,101 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 44,101 shares. During the past 18 months, 517,899 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 517,899 shares.

Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corcept Therapeutics Inc Insider Transactions

No Available Data

Alta Partners Ii Inc Mailing Address

Above is the net worth, insider trading, and ownership report for Alta Partners Ii Inc. You might contact Alta Partners Ii Inc via mailing address: One Embarcadero Center, Suite 3700, San Francisco Ca 94111.